RETRACTED: Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin

Feng Wang; Yong Yang

doi:10.1016/j.bbrc.2014.10.109

RETRACTED: Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin

Biochem Biophys Res Commun. 2014 Nov 21;454(3):465-70. doi: 10.1016/j.bbrc.2014.10.109. Epub 2014 Oct 29.

Authors

Feng Wang¹, Yong Yang²

Affiliations

¹ Department of Gastroenterology, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai 200072, People's Republic of China; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
² Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: [email protected].

PMID: 25450685
DOI: 10.1016/j.bbrc.2014.10.109

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor and the author. We have been contacted by the corresponding author Yong Yang and by Houston Methodist Research Institute, who after investigation has concluded that the data of another researcher had been copied without authorization. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.

Publication types

Retracted Publication